|
HS Code |
543057 |
As an accredited 2-Pyrimidinamine, 4-Bromo- (9CI) factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2-Pyrimidinamine, 4-Bromo- (9CI) prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
2-Pyrimidinamine, 4-Bromo- (9CI) delivers a lot more than its unassuming name might suggest. Any chemist who has spent time hunched over a bench, pipette in hand, knows how much hinges on access to well-designed, reliable intermediates. This compound stands out for its specific structure and high purity, which often brings new possibilities to both small research labs and larger production facilities. As chemical development marches forward, the need for innovative heterocyclic building blocks grows, particularly where speed and reliability mean progress or stagnation. Here, 2-Pyrimidinamine, 4-Bromo- (9CI) emerges as a strong candidate for those pushing boundaries in drug discovery, agricultural research, or even new material design.
Let’s break it down. 2-Pyrimidinamine, 4-Bromo- (9CI) carries both the pyrimidine ring and a bromo substituent, precisely at the fourth position. That single halogen makes all the difference, turning a basic scaffold into a handle that can open the door to countless downstream chemistries. It is more than a molecular curiosity. The amine group at the second position enables nucleophilic reactions, further broadening the toolbox it hands over to a synthetic chemist. This arrangement gives researchers choices—whether to target kinase inhibitors, leverage the core for antiviral candidates, or use it as the backbone in custom ligand systems. The substitution pattern isn’t just academic; it’s a matter of lab convenience and efficiency.
Researchers checking the bottle will often find the compound available in crystalline powder or sometimes fine granules, with purity standards that reflect growing expectations—usually upwards of 98%. Anyone familiar with purification headaches knows the relief of working with a substance that demands less post-purchase tinkering. Reliable suppliers back these purity claims with detailed analytical data, such as HPLC or NMR reports, not just glossy ads or vague assurances. This transparency removes many of the daily frustrations that chase chemists trying to validate pathways, as fewer side-products means fewer reruns of costly reactions.
Moisture sensitivity and storage conditions also make a difference once the lab bench comes into play. This compound typically does not break down at room temperature, so researchers save time on special handling or elaborate inert-atmosphere setups. Simple glassware usually suffices, cutting costs and reducing the learning curve for newcomers, while veterans appreciate how it fits seamlessly into a wide range of synthetic steps. Easy weighing, a neutral odor, and consistent appearance complete the picture.
There’s a practical side visible to every scientist who’s run a late-night reaction hoping for the next lead compound. 2-Pyrimidinamine, 4-Bromo- (9CI) offers a fusion of tunability and manageable reactivity. This dual nature supports downstream functionalization, crucial when researchers chase novel molecules for preclinical evaluation.
Pharmaceutical groups have increasingly homed in on the pyrimidine ring as a privileged scaffold, a trend spurred by years of successful drugs featuring this motif. The bromine atom, unlike other halogens, brings a balance of size and reactivity, allowing Suzuki or Buchwald–Hartwig coupling under reasonable conditions. Cyclizing or extending the framework often becomes simpler thanks to this functional handle, which opens up modifications unavailable to other base scaffolds.
Medicinal chemists aren’t just seeking new structures for the sake of novelty. They pursue functionalities that allow them to fine-tune biological interactions. The amino group at position two makes it straightforward to introduce structure-activity relationship (SAR) changes or to append solubilizing portions. This blend of easy coupling and modifying potential saves hours in the design-make-test-analyze loop, cutting costs and accelerating learning cycles.
Over the years, I’ve watched agricultural chemists borrow lessons from the pharmaceutical world, especially when developing agents with better selectivity or lower environmental impact. Exploring 2-Pyrimidinamine, 4-Bromo- (9CI) here, the roles differ, but the compound’s core benefits remain. The capability to build libraries of analogs by exploiting the amine and bromo sites has proven particularly helpful for designing next-generation fungicides or herbicide candidates.
Farmers and environmental scientists demand reliable solutions, not theoretical ones. The design flexibility supported by this intermediate gives researchers an edge when tailoring compounds for optimal uptake or resistance management. For anyone who’s monitored the rise of pest resistance or regulatory scrutiny on environmental persistence, the direct path this product offers is genuinely valuable.
Polymer and materials scientists also benefit. New architectures in electronics, light-emitting diodes, or even responsive coatings often rely on specialized heterocycles. The coupling potential offered by a bromo-substituted pyrimidinamine translates to higher efficiency syntheses, which, in my own experience, shifts the balance from feasibility studies to scalable prototypes. Optimizing for properties like heat tolerance or electrical behavior becomes far less daunting when the required intermediates arrive consistent and versatile.
With the rising focus on energy storage and better performing polymers, having a toolkit that allows rapid, robust assembly speeds up progress. The 4-Bromo- derivative doesn't only get used in a series of abstract reactions; it seeds breakthroughs that have implications for greener batteries, flexible electronics, and coatings that last longer under real-world conditions.
Some researchers may wonder why opt for the 4-Bromo variant over others such as 2-Pyrimidinamine, 4-Chloro- or 2-Pyrimidinamine without halogen substitution. In practice, the bromine stands out for a couple of reasons. The bond strength balances reactivity and stability: aryl bromides react under milder conditions compared to chlorides, which often demand harsher catalysts or higher temperatures. On the other hand, iodine derivatives, while even more reactive, tend to carry higher cost and less stability, often limiting their industrial appeal.
The choice of halogen doesn't just determine reactivity in a vacuum; it shapes the whole work-up and downstream manipulation. Less heat and gentler conditions often mean higher yields, fewer byproducts, and a smaller environmental footprint. Scientists looking to scale up from milligrams to kilograms find this difference can impact project viability, especially with tight budgets and increasing regulatory pressures.
For anyone who has spent days troubleshooting failed couplings with less reactive chlorinated analogs, the specific choice of bromo certainly feels more than academic. It speeds up proof of concept work, helps hit delivery timelines, and keeps projects alive in an era of shrinking R&D dollars.
Scientists in both early discovery and late-stage manufacturing know unpredictable intermediates can throw an entire project off track. My own work in process development taught me to prize suppliers who provide compound with reproducible quality and thorough documentation. The best sources for 2-Pyrimidinamine, 4-Bromo- (9CI) prioritize lot-to-lot consistency, making scaling much more reliable.
Traceability, supported by batch-specific analytical certificates, lets teams build reliable platforms, not just one-off syntheses. Knowing that each shipment stacks up to the same rigorous standards, without surprise impurities or formulation issues, smooths regulatory review and reduces troubleshooting. This reliability counts for a lot, since failed scaleups waste both time and material.
Many companies and academic labs work within established synthetic routes, without the flexibility to reinvent processes for every new target. 2-Pyrimidinamine, 4-Bromo- (9CI) easily fits into widely-used synthetic frameworks. The bromo handle works well with a variety of palladium-catalyzed methodologies, which have become staple reactions for medicinal and material chemists. Retrofitting reactions to include this intermediate takes little adjustment, which saves both retraining time and resources.
Standard solvents and conditions remain compatible, sparing researchers the headache of chasing specialty reagents or exotic catalysts. This real-world convenience often goes unmentioned in sterile product listings, but in practice, it makes the difference between a promising lead and an abandoned series.
Regulatory expectations have tightened, and I’ve seen firsthand how early planning with clean, manageable intermediates reduces last-minute drama. Choosing 2-Pyrimidinamine, 4-Bromo- (9CI) makes it easier to maintain clean processes and meet compliance benchmarks for pharmaceutical and agrochemical regulations. Fewer byproducts, less frequent need for toxic solvent washes, and milder processing temperatures all align with both health and sustainability goals set by many organizations.
Waste minimization becomes simpler, and wastewater treatment doesn’t spiral out of control. Since many companies face increasing pressure to provide thorough environmental impact assessments, cleaner synthesis enabled by well-characterized intermediates reduces negative surprises. The domino effect from these early choices can often be traced back months or even years later as regulatory and safety reviews progress.
No compound provides a magic bullet for every synthetic challenge. In my own work, I’ve run into limits where the reactivity of the bromo group led to side-reactions, or analytical difficulty tracing minor impurities. Thoughtful planning and method development sidestep a lot of these headaches, so teams working with 2-Pyrimidinamine, 4-Bromo- (9CI) benefit from tried-and-true protocols. Up-to-date literature and method sharing smooth the learning process, letting new researchers pick up where others leave off.
Close collaboration with suppliers also pays dividends. Not every manufacturer delivers the same quality or transparency, so establishing clear specifications and early quality checks keeps projects running smoothly. Small pilot batches sometimes uncover unexpected sensitivity to temperature swings or container material, lessons best learned away from the main production line. Good communication between laboratories and procurement teams amplifies these lessons, reinforcing a culture of continuous improvement.
One persistent headache in the supply chain world is the risk of interrupted shipments or inconsistent purity. Chemical manufacturers are increasingly investing in better synthesis routes, including greener reagents and less solvent-intensive methods. By optimizing purification steps, they help deliver on both cost control and environmental expectations. I’ve found that close relationships with suppliers—which sometimes means a couple of extra calls and emailed questions—often reveal opportunities for custom packaging or shipment tracking that smooth out bumps down the road.
Internally, labs that develop robust analytical protocols—NMR, HPLC, and GC among them—find out quickly if changes in purity or formulation creep in. Including backup suppliers on approved supplier lists, and running routine parallel tests before committing large-scale processes, help avoid dramatic failures. Cross-training team members on troubleshooting further shores up the operation, as knowledge about subtle changes in melting point or color can sometimes solve what looks like a major production crisis.
Waste handling and sustainability pose another ongoing challenge for today’s chemistry teams. Utilizing intermediates like 2-Pyrimidinamine, 4-Bromo- (9CI) that support milder conditions and produce fewer side-products often unlocks simpler disposal methods, lowering operating costs. Advances in continuous flow chemistry provide another promising direction, as reaction times shorten and waste streams become easier to control. The industry trend reflects lessons learned: picking the right intermediate up front cuts headaches, cost, and environmental burden throughout the product’s lifecycle.
In drug discovery, every step shaved from a synthesis matters. The gift of a modular, well-behaved intermediate like 2-Pyrimidinamine, 4-Bromo- (9CI) is more than the sum of its atoms; it represents months of saved effort and smoother handoffs between teams. I’ve worked in settings where one molecule like this unlocked whole series of SAR explorations that previously stalled out. Progress in the lab translates quickly to new hypotheses, grant proposals, and ultimately, advances that ripple out into public health or food security.
Success builds on reliability, and reliability depends on good material and clear documentation. This feedback loop, visible to anyone who’s watched a project pivot from troubleshooting to breakthrough, underscores why compound selection deserves more than a line in the methods section. The right building blocks, sourced wisely and handled with care, transform aspirations into achievements—one reaction at a time.
Anyone setting out to expand into pyrimidine-based research should make a point of starting with a small trial. Running parallel reactions to map out reactivity and analyze side products under relevant conditions helps avoid wasted resources down the line. Reading current patent and journal literature highlights best practices, since the fastest teams usually leverage collective experience rather than reinventing common steps.
Developing a good relationship with the supplier—requesting batch-specific analytical data, negotiating flexible quantities, or confirming storage conditions—brings peace of mind and higher yield at scale. Academic lab directors and R&D leads both benefit from tracing how small improvements in starting material quality echo out into bigger project successes.
2-Pyrimidinamine, 4-Bromo- (9CI) illustrates the growing sophistication of chemical synthesis and the practical gains that clear, well-characterized intermediates offer across disciplines. The compound’s unique balance of robust reactivity and stability provides a springboard for discoveries in pharmaceuticals, agriculture, and beyond. Lessons from hard-won project successes and the occasional setback all reinforce a simple truth: picking the right tools and knowing their strengths increases the pace of innovation, delivers more reliable results, and supports both financial and environmental responsibility.
As research communities look to solve bigger challenges—from global health to new materials—it pays to invest in intermediates that remove barriers instead of creating them. For any scientist or process engineer shaping the next breakthrough, the journey often begins with that first, well-considered reagent—and sometimes, 2-Pyrimidinamine, 4-Bromo- (9CI) is just the catalyst you need to get there.